Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |